AnalystsDifei YangDifei Yang's Stock Forecasts
AnalystsDifei Yang
Analyst Ranking
Top 14%
#661 out of 4875 analysts
Average Return
+9.14%
Win Rate
35%14 out of 40
Risk vs Reward
Poor
Good
Difei Yang's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Zogenix IncZGNX | +205.83% | $15.45 | $47.25 | 2017-09-07 - 2018-09-07 | Strong Buy |
Nektar TherapeuticsNKTR | +163.68% | $23.10 | $60.91 | 2017-09-27 - 2018-09-27 | Strong Buy |
Novocure LtdNVCR | +134.83% | $20.10 | $47.20 | 2017-09-07 - 2018-09-07 | Strong Buy |
Concert Pharmaceuticals IncCNCE | +125.93% | $2.97 | $6.71 | 2021-10-05 - 2022-10-04 | Strong Buy |
Revance Therapeutics IncRVNC | +122.54% | $12.60 | $28.04 | 2020-04-01 - 2021-04-01 | Strong Buy |
Difei Yang Analyst Color
Get additional color on Difei Yang's coverage of popular stocks
Difei Yang's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Dianthus Therapeutics IncDNTH | 2 | Strong Buy | $8.00 | N/A | Maintains | 3 years ago |
Akebia Therapeutics IncAKBA | 2 | Hold | $2.00 | N/A | Downgrades | 3 years ago |
Concert Pharmaceuticals IncCNCE | 4 | Strong Buy | $9.00 | N/A | Maintains | 4 years ago |
Bluebird Bio IncBLUE | 3 | Strong Buy | $460.00 | N/A | Maintains | 4 years ago |
Novocure LtdNVCR | 5 | Hold | $200.00 | N/A | Maintains | 4 years ago |
Eloxx Pharmaceuticals IncELOX | 1 | Strong Buy | $124.00 | N/A | Initiates Coverage On | 4 years ago |
Casi Pharmaceuticals IncCASI | 1 | Strong Buy | $38.00 | N/A | Initiates Coverage On | 4 years ago |
Fibrogen IncFGEN | 3 | Hold | $29.00 | N/A | Downgrades | 4 years ago |
Uniqure NvQURE | 3 | Strong Buy | $52.00 | N/A | Upgrades | 4 years ago |
Freeline Therapeutics Holdings PLCFRLN | 1 | Strong Buy | $405.00 | N/A | Initiates Coverage On | 4 years ago |
Sarepta Therapeutics IncSRPT | 2 | Strong Buy | $160.00 | N/A | Maintains | 4 years ago |
Cartesian Therapeutics IncRNAC | 2 | Strong Buy | $8.00 | N/A | Upgrades | 4 years ago |
Xeris Biopharma Holdings IncXERS | 1 | Strong Buy | $14.00 | N/A | Maintains | 5 years ago |
Aerie Pharmaceuticals IncAERI | 2 | Strong Buy | $36.00 | N/A | Maintains | 5 years ago |
Revance Therapeutics IncRVNC | 2 | Strong Buy | $35.00 | N/A | Maintains | 5 years ago |
Zogenix IncZGNX | 3 | Strong Buy | $64.00 | N/A | Maintains | 5 years ago |
Nektar TherapeuticsNKTR | 2 | Strong Buy | $35.00 | N/A | Upgrades | 5 years ago |
Viveve Medical IncVIVE | 2 | Sell | $200.00 | N/A | Downgrades | 6 years ago |
Marinus Pharmaceuticals IncMRNS | 2 | Hold | $20.00 | N/A | Downgrades | 6 years ago |
Spark Therapeutics IncONCE | 2 | Hold | N/A | N/A | Downgrades | 6 years ago |
Audentes Therapeutics IncBOLD1 | 2 | Strong Buy | N/A | N/A | Upgrades | 7 years ago |
Avexis IncAVXS | 2 | Hold | $218.00 | N/A | Downgrades | 7 years ago |
Regenxbio IncRGNX | 1 | Hold | $28.00 | N/A | Initiates Coverage On | 7 years ago |
Heron Therapeutics IncHRTX | 1 | Strong Buy | $28.00 | N/A | Initiates Coverage On | 8 years ago |
Viewray IncVRAYQ | 1 | Strong Buy | $12.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.